Pfizer in talks to merge off-patent drugs business with Mylan -source
July 27, 2019
LSE’s bid for Refinitiv spotlights quest for data, globality
July 28, 2019

Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.

Powered by WPeMatico